Frontage's COVID-19 Response to Our Valued Partners
Register to gain access to gated resources.
Thank you for registering!
You now have the option of downloading the resource or viewing the web version below.
At Frontage Labs, we work closely with biopharma sponsors globally to provide solutions to support the development of new therapeutics, vaccines, and testing kits. Our labs are open and fully operational to support your immediate project needs. We have the ability to process COVID-19 molecular and antibody testing, in addition to COVID-19+ positive PK and PD samples.
Please register for a guided virtual tour of Frontage's DMPK facility.
Frontage’s newest facility in Hayward, CA started operations in 2022. With over 19,000 in. square footage, it supports bioanalytical and biologics projects. The Biologics Services Department provides exploratory and GLP-compliant Ligand Binding Assay (LBA) services to biotech and pharmaceutical industries, supporting pharmacokinetics (PK), immunogenicity (ADA), and biomarker analysis for protein therapeutics. The Bioanalytical Services Department provides R&D and GLP-compliant, quantitative mass spectrometry services to biotech and pharmaceutical industries, supporting all preclinical and clinical PK / TK / DDI / BA / BE, protein binding, and biomarker studies.